274 related articles for article (PubMed ID: 33617900)
21. c-Cbl is a critical modulator of the Ron tyrosine kinase receptor.
Penengo L; Rubin C; Yarden Y; Gaudino G
Oncogene; 2003 Jun; 22(24):3669-79. PubMed ID: 12802274
[TBL] [Abstract][Full Text] [Related]
22. Structure of the amino-terminal domain of Cbl complexed to its binding site on ZAP-70 kinase.
Meng W; Sawasdikosol S; Burakoff SJ; Eck MJ
Nature; 1999 Mar; 398(6722):84-90. PubMed ID: 10078535
[TBL] [Abstract][Full Text] [Related]
23. Distinct turnover of alternatively spliced isoforms of the RET kinase receptor mediated by differential recruitment of the Cbl ubiquitin ligase.
Scott RP; Eketjäll S; Aineskog H; Ibáñez CF
J Biol Chem; 2005 Apr; 280(14):13442-9. PubMed ID: 15677445
[TBL] [Abstract][Full Text] [Related]
24. Negative regulation of FcepsilonRI-mediated mast cell activation by a ubiquitin-protein ligase Cbl-b.
Qu X; Sada K; Kyo S; Maeno K; Miah SM; Yamamura H
Blood; 2004 Mar; 103(5):1779-86. PubMed ID: 14604964
[TBL] [Abstract][Full Text] [Related]
25. The Src-like adaptor protein regulates PDGF-induced actin dorsal ruffles in a c-Cbl-dependent manner.
Sirvent A; Leroy C; Boureux A; Simon V; Roche S
Oncogene; 2008 May; 27(24):3494-500. PubMed ID: 18193084
[TBL] [Abstract][Full Text] [Related]
26. The Cbl family proteins: ring leaders in regulation of cell signaling.
Swaminathan G; Tsygankov AY
J Cell Physiol; 2006 Oct; 209(1):21-43. PubMed ID: 16741904
[TBL] [Abstract][Full Text] [Related]
27. The tyrosine kinase negative regulator c-Cbl as a RING-type, E2-dependent ubiquitin-protein ligase.
Joazeiro CA; Wing SS; Huang H; Leverson JD; Hunter T; Liu YC
Science; 1999 Oct; 286(5438):309-12. PubMed ID: 10514377
[TBL] [Abstract][Full Text] [Related]
28. Cbl-mediated degradation of Lyn and Fyn induced by constitutive fibroblast growth factor receptor-2 activation supports osteoblast differentiation.
Kaabeche K; Lemonnier J; Le Mée S; Caverzasio J; Marie PJ
J Biol Chem; 2004 Aug; 279(35):36259-67. PubMed ID: 15190072
[TBL] [Abstract][Full Text] [Related]
29. CD2-associated protein (CD2AP) enhances casitas B lineage lymphoma-3/c (Cbl-3/c)-mediated Ret isoform-specific ubiquitination and degradation via its amino-terminal Src homology 3 domains.
Calco GN; Stephens OR; Donahue LM; Tsui CC; Pierchala BA
J Biol Chem; 2014 Mar; 289(11):7307-19. PubMed ID: 24425877
[TBL] [Abstract][Full Text] [Related]
30. The protein product of the c-cbl oncogene rapidly complexes with the EGF receptor and is tyrosine phosphorylated following EGF stimulation.
Bowtell DD; Langdon WY
Oncogene; 1995 Oct; 11(8):1561-7. PubMed ID: 7478580
[TBL] [Abstract][Full Text] [Related]
31. Negative regulation of Lck by Cbl ubiquitin ligase.
Rao N; Miyake S; Reddi AL; Douillard P; Ghosh AK; Dodge IL; Zhou P; Fernandes ND; Band H
Proc Natl Acad Sci U S A; 2002 Mar; 99(6):3794-9. PubMed ID: 11904433
[TBL] [Abstract][Full Text] [Related]
32. Cbl escapes Cdc42-mediated inhibition by downregulation of the adaptor molecule betaPix.
Schmidt MHH; Husnjak K; Szymkiewicz I; Haglund K; Dikic I
Oncogene; 2006 May; 25(21):3071-8. PubMed ID: 16407834
[TBL] [Abstract][Full Text] [Related]
33. Cloning and characterization of human Src-like adaptor protein 2 and a novel splice isoform, SLAP-2-v.
Loreto MP; McGlade CJ
Oncogene; 2003 Jan; 22(2):266-73. PubMed ID: 12527895
[TBL] [Abstract][Full Text] [Related]
34. E3 ubiquitin ligase Cbl-b in innate and adaptive immunity.
Liu Q; Zhou H; Langdon WY; Zhang J
Cell Cycle; 2014; 13(12):1875-84. PubMed ID: 24875217
[TBL] [Abstract][Full Text] [Related]
35. Activation of Epstein-Barr virus/C3d receptor (gp140, CR2, CD21) on human B lymphoma cell surface triggers Cbl tyrosine phosphorylation, its association with p85 subunit, Crk-L and Syk and its dissociation with Vav.
Lottin-Divoux S; Jean D; Le Romancer M; Frade R
Cell Signal; 2006 Aug; 18(8):1219-25. PubMed ID: 16289966
[TBL] [Abstract][Full Text] [Related]
36. The Ubiquitin Ligases c-Cbl and Cbl-b Negatively Regulate Platelet-derived Growth Factor (PDGF) BB-induced Chemotaxis by Affecting PDGF Receptor β (PDGFRβ) Internalization and Signaling.
Rorsman C; Tsioumpekou M; Heldin CH; Lennartsson J
J Biol Chem; 2016 May; 291(22):11608-18. PubMed ID: 27048651
[TBL] [Abstract][Full Text] [Related]
37. Cbl enforces an SLP76-dependent signaling pathway for T cell differentiation.
Chiang YJ; Jordan MS; Horai R; Schwartzberg PL; Koretzky GA; Hodes RJ
J Biol Chem; 2009 Feb; 284(7):4429-38. PubMed ID: 19074136
[TBL] [Abstract][Full Text] [Related]
38. Autoinhibition and phosphorylation-induced activation mechanisms of human cancer and autoimmune disease-related E3 protein Cbl-b.
Kobashigawa Y; Tomitaka A; Kumeta H; Noda NN; Yamaguchi M; Inagaki F
Proc Natl Acad Sci U S A; 2011 Dec; 108(51):20579-84. PubMed ID: 22158902
[TBL] [Abstract][Full Text] [Related]
39. Phosphotyrosine binding domain-dependent upregulation of the platelet-derived growth factor receptor alpha signaling cascade by transforming mutants of Cbl: implications for Cbl's function and oncogenicity.
Bonita DP; Miyake S; Lupher ML; Langdon WY; Band H
Mol Cell Biol; 1997 Aug; 17(8):4597-610. PubMed ID: 9234717
[TBL] [Abstract][Full Text] [Related]
40. E3 ubiquitin ligase Cbl-b regulates Pten via Nedd4 in T cells independently of its ubiquitin ligase activity.
Guo H; Qiao G; Ying H; Li Z; Zhao Y; Liang Y; Yang L; Lipkowitz S; Penninger JM; Langdon WY; Zhang J
Cell Rep; 2012 May; 1(5):472-82. PubMed ID: 22763434
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
